Blog

All Posts
    Orsini Specialty Pharmacy
    • Oct 27
    • 2 min read
    Orsini Specialty Pharmacy
    • Oct 27
    • 2 min

    Choosing a Specialty Pharmacy to Support Mucopolysaccharidosis (MPS) Patients

    Mucopolysaccharidosis (MPS) is an inherited metabolic disease in which the body does not produce enough enzymes to break down sugars into simpler...
    Write a comment
    Orsini Specialty Pharmacy
    • May 13
    • 1 min read
    Orsini Specialty Pharmacy
    • May 13
    • 1 min

    8 Facts to Know About Mucopolysaccharidosis on MPS Awareness Day

    Mucopolysaccharidosis (MPS) is a rare disease in which the body is missing or does not have enough of an enzyme needed to break down long chains of...
    Write a comment

    Orsini is a leading independent national specialty pharmacy accredited by ACHC, JCAHO, URAC, and VIPPS. The services we provide allow patients, physicians, payors, and manufacturers to improve care, simplify processes, and achieve better outcomes.

    Learn More

    Recent Posts

    Orsini Specialty Pharmacy Names Darin DeCarlo Chief Growth Officer

    Aug 30, 2023

    Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ™ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease

    Aug 23, 2023

    Orsini Selected by BioMarin to Dispense ROCTAVIAN™, the First Gene Therapy for the Treatment of Severe Hemophilia A

    Jul 11, 2023

    Optimizing Patient Care Services with Rare Disease Limited Distribution Drugs

    Jun 29, 2023

    Orsini Selected by Sarepta Therapeutics to Dispense ELEVIDYS (delandistrogene moxeparvovec-rokl), the First Gene Therapy to Treat Duchenne Muscular Dystrophy

    Jun 27, 2023
    [Whitepaper] Payor Considerations When Choosing a Specialty Pharmacy